Latest:

Fat Pitch Financials

Special situation stocks and value investing

Stock Quote

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Amarin Corp Ads (NQ: AMRN )

4.850 USD -0.080 (-1.62%)
Streaming Delayed Price Updated: 10:09 AM EDT, Jun 18, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Amarin Corp Ads

< Previous 1 2 3 4 5 6 7 8 9
...
89 90 Next >
Understanding Amarin Corp's Unusual Options Activity
Amarin Corp (NASDAQ:AMRN) shares experienced unusual options activity on Wednesday. The stock price moved up to $5.02 following the ... 
Tags Market News Benzinga Markets
From Benzinga
Market Briefing For Tuesday, Jun. 8
Benign market behavior generally persists; as an out-of-the-box rally effort to start Monday was reversed, as is typical since traders want a pullback first. 
Tags Market News Pharma/Biotech Stocks / Equities
From Blogs - TalkMarkets
Further Insights into Mechanism of Action of Icosapent Ethyl and Its Unique Form of Eicosapentaenoic Acid (EPA) Presented at the European Atherosclerosis Society (EAS) Congress 2021
Studies support potentially important anti-inflammatory, protein modulation, and cell function effects of icosapent ethyl as known by the brand name VASCEPA® in much of the world and as VAZKEPA in... 
From GlobeNewswire News Releases
PPH's Holdings Imply 14% Gain Potential
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Why Amarin Trounced the Market on Tuesday
Investors reacted positively to a company presentation at an industry convention. 
Tags Market News AMRN
From Motley Fool
Amarin to Present at Two Investor Conferences in June 2021
From GlobeNewswire News Releases
Amarin Highlights Multiple Scientific Findings for VASCEPA® (Icosapent Ethyl) and Its Unique Active Ingredient at the American College of Cardiology’s 70th Annual Scientific Session
From GlobeNewswire News Releases
REDUCE-IT® Heart Failure Analyses by VASCEPA® (Icosapent Ethyl)-Driven Serum Eicosapentaenoic Acid (EPA) Levels Suggest Potential Benefit in New Heart Failure in Studied At-Risk Patients as Presented
From GlobeNewswire News Releases
Why Amarin Stock Is Tumbling Today
An analyst downgraded the drugmaker. 
Tags AMRN Market News
From Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For May 12, 2021
Upgrades Craig-Hallum upgraded the previous rating for ShotSpotter Inc (NASDAQ:SSTI) from Hold to Buy. For the first ... 
Tags Analyst Ratings BZI/Ratings AMRN
From Benzinga
10 Biggest Price Target Changes For Wednesday
HC Wainwright & Co. lowered Novavax, Inc. (NASDAQ: NVAX) price target from $317 to $294. Novavax shares fell 1.6% to $136.00 in ... 
Tags BIGC Price Target Changes CCEP
From Benzinga
Relative Strength Alert For Amarin
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a... 
Tags Stocks
From Market News Video
Clinical Data and Other Research Results Regarding VASCEPA® (Icosapent Ethyl) and Its Unique Active Ingredient to Be Presented at the American College of Cardiology’s 70th Annual Scientific Session
Amarin-Supported Research and Analyses from Academic Collaborators to Be Featured in Seven Presentations, Including REDUCE-IT® Heart Failure and Additional Analyses from EVAPORATE 
From GlobeNewswire News Releases
Amarin (AMRN) Q1 2021 Earnings Call Transcript
AMRN earnings call for the period ending March 31, 2021. 
Tags Market News AMRN
From Motley Fool
AMRN June 11th Options Begin Trading
Investors in Amarin Corp plc (AMRN) saw new options become available today, for the June 11th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the AMRN options chain... 
Tags Stocks
From Market News Video
The Daily Biotech Pulse: Clinical Setback For Adverum, Galera Posts Data Readout, Moderna To Invest In Vaccine Manufacturing, Decision Day For Ardelyx
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags MMSI WST PRAH
From Benzinga
Amarin: Q1 Earnings Insights
Shares of Amarin Corp (NASDAQ:AMRN) rose 2.5% in pre-market trading after the company reported Q1 results. Quarterly ... 
Tags BZI/Recaps AMRN News
From Benzinga
Amarin Reports First Quarter 2021 Financial Results and Provides Business Update
From GlobeNewswire News Releases
Amarin Announces Planned Retirement of Joseph T. Kennedy, EVP, General Counsel
From GlobeNewswire News Releases
The Week Ahead In Biotech (April 25-May 1): FDA Decisions For Sol-Gel, Protalix Bio, Ardelyx
Biopharma stocks came back from the weakness seen in the first two sessions to close the week ended April 23 higher. Johnson & ... 
Tags MDXG GILD OPK
From Benzinga
Interesting AMRN Put And Call Options For June 4th
Investors in Amarin Corp plc (AMRN) saw new options become available today, for the June 4th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the AMRN options chain... 
Tags Stocks
From Market News Video
Amarin Receives Great Britain Marketing Authorization for VAZKEPA from the Medicines and Healthcare Products Regulatory Agency (MHRA) 1,2
From GlobeNewswire News Releases
Implied IBB Analyst Target Price: $194
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Amarin to Report First Quarter Results and Host Conference Call on April 29, 2021
From GlobeNewswire News Releases
VASCEPA® (Icosapent Ethyl) Reported to Impact Vulnerable Coronary Plaque Features in New Analyses of EVAPORATE Study Presented as Late-Breaking Science at ESC Preventive Cardiology 2021
From GlobeNewswire News Releases
Cramer Weighs In On Paysafe, Xilinx And More
On CNBC's "Mad Money Lightning Round," Jim Cramer said Keysight Technologies Inc (NYSE: KEYS) has been just red hot and he ... 
Tags CNBC KEYS mad money Lightning Round
From Benzinga
50 Biggest Movers From Yesterday
Gainers Mackinac Financial Corporation (NASDAQ: MFNC) shares surged 60.7% to close at $21.16 on Tuesday after the company, and ... 
Tags ZLAB Markets UNAM
From Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers NovoCure (NASDAQ:NVCR) shares rose 42.08% to $187.38 during Tuesday's regular session. Trading volume for ... 
Tags Markets Market News Benzinga
From Benzinga
Why Amarin Stock Is Sinking Today
The company's CEO announced his retirement. 
Tags MRK Market News AMRN
From Motley Fool
The Daily Biotech Pulse: Leadership Transition At Amarin, Vaccine Setback For J&J, FDA Nod For Label Expansion of Roche's Asthma Drug
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags TLSA MDT Penny Stocks
From Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
89 90 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.